Mosapride Combined with Dai Lixin on the Treatment of Functional Dyspepsia Clinical Efficacy

Objective:To observe the clinical efficacy of clinical application mosapride combined with Dai Lixin,combination therapy of functional dyspepsia.Method:120 cases of patients with functional dyspepsia in our hospital from January 2010 to December 2011 were randomly divided into control group and observation group,60 patients of the control group were treated with mosapride,while the observation group 60 patients were given mosapride combined with Dai Lixin combination therapy,the clinical outcomes of the two groups were observed.Result:The clinical observation group total effective rate was 95.0%,total effective rate was 78.3% in the clinical treatment of the control group,two sets of data with significant differences(P0.05),statistically meaningful,observed adverse reactions was 21.7%,adverse reactions was 18.3% in the control group,two groups of data was no significant difference(P0.05),statistically meaningless.Conclusion:Clinical functional dyspepsia to take mosapride combined with Dai Lixin,new combination therapy has a better effect,can improve the clinical efficacy and fewer adverse reactions,worthy of clinical application.